Zobrazeno 1 - 10
of 13
pro vyhledávání: '"Walter P, Jeske"'
Autor:
Jeanine M. Walenga PhD, Tania A. Torres BS, Walter P. Jeske PhD, Jeffrey Schwartz MD, Vicki Escalante BS, Joshua D. Newman MD, Mamdouh Bakhos MD
Publikováno v:
Clinical and Applied Thrombosis/Hemostasis, Vol 26 (2020)
Use of left ventricular assist devices (LVADs) for management of advanced heart failure is becoming increasingly common; however, device associated thrombosis remains an important cause of mortality in this patient population. We hypothesize that inf
Externí odkaz:
https://doaj.org/article/948e0fb5ee4c440ea1ba61097006ec88
Autor:
Nicholas C. Brehl, Michelle Butina, Karen S. Clark, Magdalena Czader, Phillip J. DeChristopher, Heather DeVries, Kathryn Doig, George A. Fritsma, Bertil Glader, Linda H. Goossen, Teresa G. Hippel, S. Renee Hodgkins, Debra A. Hoppensteadt, Cynthia L. Jackson, Walter P. Jeske, Elaine M. Keohane, Ameet R. Kini, Clara Lo, Naveen Manchanda, Steven Marionneaux, Peter Maslak, Shashi Mehta, Kamran M. Mirza, Jo Ann Molnar, Reeba A. Omman, Catherine N. Otto, Ruth Perez, Tim R. Randolph, Kathleen M. Sakamoto, Gail H. Vance, Carolina Vilchez, Jeanine M. Walenga, Destiny D. Whitfield
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::946951df143d4d491fd1facf6521994c
https://doi.org/10.1016/b978-0-323-53045-3.00006-4
https://doi.org/10.1016/b978-0-323-53045-3.00006-4
Publikováno v:
Turkish journal of haematology : official journal of Turkish Society of Haematology. 19(2)
Fondaparinux (Arixtra®; Sanofi-Synthélabo/Organon) is the first of a new class of antithrombotic agents distinct from low molecular weight (LMW) heparins and heparin. It is a synthetic pentasaccharide mimicking the site of heparin that binds to ant
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::29a7af5b5303bab0f746ce15d13bcc49
https://pubmed.ncbi.nlm.nih.gov/27264755
https://pubmed.ncbi.nlm.nih.gov/27264755
Publikováno v:
Methods in molecular biology (Clifton, N.J.). 663
The clinical effects of heparin are meritorious and heparin remains the anticoagulant of choice for most clinical needs. However, as with any drug, adverse effects exist. Heparin-induced thrombocytopenia (HIT) is an important adverse effect of hepari
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::b291d2ebf6bbfa224a34ca8571a31c72
https://pubmed.ncbi.nlm.nih.gov/20617416
https://pubmed.ncbi.nlm.nih.gov/20617416
Publikováno v:
Methods in molecular biology (Clifton, N.J.). 663
Novel adenosine diphosphate (ADP) P2Y(12) antagonists such as prasugrel, ticagrelor, cangrelor, and elinogrel are in various phases of clinical development. These ADP P2Y(12) antagonists have advantages over clopidogrel ranging from faster onset to g
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::8045562d0ddcd675538bff73af5aab70
https://pubmed.ncbi.nlm.nih.gov/20617420
https://pubmed.ncbi.nlm.nih.gov/20617420
Autor:
Ariane I. de Agostini, Xingbin Ai, Karen J. Bame, Benito Casu, Ishan Capila, William E. Dager, Umesh R. Desai, Matteo Nicola Dario Di Minno, Ji-Cui Dong, Elazer R. Edelman, R. Erik Edens, Charles P. Emerson, Jawed Fareed, Maria Fuller, Kimberly Forsten-Williams, Hari G. Garg, Ian A. Greer, Nur Sibel Gunay, Charles A. Hales, Nicholas J. Harmer, Debra A. Hoppensteadt, John J. Hopwood, Ghamartaj Hosseini, James A. Huntington, Omer Iqbal, Walter P. Jeske, Morris J. Karnovsky, Michael G. Kinsella, Hiroshi Kitagawa, Mehmet E. Korkmaz, Marion Kusche-Gullberg, Ulf Lindahl, Robert J. Linhardt, Caini Liu, Dongfang Liu, Peter J. Meikle, Shuji Mizumoto, Shaker A. Mousa, Eva M. Munoz, Annamaria Naggi, Christian Noti, Matthew A. Nugent, Marc Princivalle, Tim Rudd, Ram Sasisekharan, Peter H. Seeberger, Zachary Shriver, Mark A. Skidmore, Kazuyuki Sugahara, Andrew A. Thomson, Antonella Tufano, Jeremy E. Turnbull, Sandra G. Velleman, Ganesh Venkataraman, Jeanine M. Walenga, Theodore E. Warkentin, Thomas N. Wight, Edwin A. Yates, Haining Yu
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::d6753f2c7993057b60176b026466c880
https://doi.org/10.1016/b978-008044859-6/50001-0
https://doi.org/10.1016/b978-008044859-6/50001-0
Publikováno v:
Methods in molecular medicine. 93
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::60193d609622bb5102418f987b1ea5a0
https://pubmed.ncbi.nlm.nih.gov/14733329
https://pubmed.ncbi.nlm.nih.gov/14733329
Publikováno v:
Methods in molecular medicine. 93
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::c5dc96b476db86e0164a9444eddc339a
https://pubmed.ncbi.nlm.nih.gov/14733330
https://pubmed.ncbi.nlm.nih.gov/14733330
Publikováno v:
Methods in molecular medicine. 93
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::7230e50787932a2a1330774e1633f7ef
https://pubmed.ncbi.nlm.nih.gov/14733335
https://pubmed.ncbi.nlm.nih.gov/14733335